Evaluating heparin-induced thrombocytopenia: The old and the new

Seminars in Thrombosis and Hemostasis

Volumn 38, Issue 2, 2012, Pages 135-143

  Tan, Chee Wee ^a,b   Ward, Christophermorice ^a,b   Morel Kopp, Marie Christine ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

clinical scoring; functional assays; heparin induced thrombocytopenia; heparin platelet factor 4 enzyme immunoassays; heparin platelet factor 4 particle gel immunoassay

Indexed keywords

ANTITHROMBOCYTIC AGENT; HEPARIN; IMMUNOGLOBULIN G ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; POLYVINYL DERIVATIVE; POLYVINYL SULFATE; THROMBIN; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG;

ANTIBODY TITER; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPLEX FORMATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DONOR SELECTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; HEPARIN INDUCED THROMBOCYTOPENIA; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; LABORATORY TEST; LIGHT TRANSMISSION AGGREGOMETRY; OPTICAL DENSITY; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROLOGY; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY; WHOLE BLOOD IMPEDANCE AGGREGOMETRY;

ANTIBODIES; BLOOD PLATELETS; CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPARIN; HUMANS; IMMUNOGLOBULIN G; PLATELET AGGREGATION; PLATELET COUNT; PLATELET FACTOR 4; SENSITIVITY AND SPECIFICITY; SEROTONIN; THROMBOCYTOPENIA;

EID: 84858126548     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1301411     Document Type: Review

References (82)

1. Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytopenia. Chest: 2005; 127 2, Suppl 35S 45S (Pubitemid 40224080)
2. Denys B, Stove V, Philipp J, Devreese K. A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia. Thromb Res: 2008; 123 1 137 145
3. Greinacher A. Heparin-induced thrombocytopenia. J Thromb Haemost: 2009; 7 Suppl 1 9 12
4. Selleng K, Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med: 2007; 35 4 1165 1176 (Pubitemid 46598970)
5. Selleng K, Selleng S, Greinacher A. Heparin-induced thrombocytopenia in intensive care patients. Semin Thromb Hemost: 2008; 34 5 425 438
6. Sakr Y. Heparin-induced thrombocytopenia in the ICU: an overview. Crit Care: 2011; 15 2 211
7. Warkentin TE, Sheppard JA. Testing for heparin-induced thrombocytopenia antibodies. Transfus Med Rev: 2006; 20 4 259 272 (Pubitemid 44428106)
8. Schenk S, El-Banayosy A, Morshuis M., et al. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support. J Thromb Haemost: 2007; 5 2 235 241 (Pubitemid 46139443)
9. Kannan M, Ahmad S, Fareed J, Saxena R. Diagnostic strategy in heparin induced thrombocytopenia. Eastern J Med: 2009; 14 78 83
10. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol: 2003; 121 4 535 555 (Pubitemid 36645375)
11. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost: 2006; 4 4 759 765
12. Pouplard C, Gueret P, Fouassier M., et al. Prospective evaluation of the 4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost: 2007; 5 7 1373 1379 (Pubitemid 46965362)
13. Crowther MA, Cook DJ, Albert M., et al. Canadian Critical Care Trials Group. The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients. J Crit Care: 2010; 25 2 287 293
14. Cuker A, Arepally G, Crowther MA., et al. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost: 2010; 8 12 2642 2650
15. Berry C, Tcherniantchouk O, Ley EJ., et al. Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients. J Am Coll Surg: 2011; 213 1 10 17, discussion 17-18
16. Bryant A, Low J, Austin S, Joseph JE. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay. Br J Haematol: 2008; 143 5 721 726
17. Greinacher A, Selleng K. Thrombocytopenia in the intensive care unit patient. Hematology (Am Soc Hematol Educ Program): 2010; 2010 135 143
18. Bakchoul T, Giptner A, Najaoui A, Bein G, Santoso S, Sachs UJ. Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost: 2009; 7 8 1260 1265
19. Bidet A, Tardy Poncet B, Desprez D., et al. GEHT-HIT study group. Clinical characteristics and laboratory testing of patients with suspected HIT: a survey on current practice in 11 university hospitals in France. Thromb Res: 2010; 125 6 e294 e299
20. Otis SA, Zehnder JL. Heparin-induced thrombocytopenia: current status and diagnostic challenges. Am J Hematol: 2010; 85 9 700 706
21. Ruf KM, Bensadoun ES, Davis GA, Flynn JD, Lewis DA. A clinical-laboratory algorithm incorporating optical density value to predict heparin-induced thrombocytopenia. Thromb Haemost: 2011; 105 3 553 559
22. Amiral J, Bridey F, Dreyfus M., et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost: 1992; 68 1 95 96
23. Greinacher A, Juhl D, Strobel U., et al. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes. J Thromb Haemost: 2007; 5 8 1666 1673 (Pubitemid 47091409)
24. Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol: 2007; 82 12 1037 1043 (Pubitemid 350209843)
25. Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost: 2008; 6 8 1304 1312 (Pubitemid 352016309)
26. Eichler P, Raschke R, Lubenow N, Meyer O, Schwind P, Greinacher A. The new ID-heparin/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays. Br J Haematol: 2002; 116 4 887 891 (Pubitemid 34227011)
27. Tazzari PL, Ricci F, Vitale M., et al. Heparin-induced thrombocytopenia: detection of antiheparin/PF4 antibodies by means of heparin/PF4-coated beads and flow cytometry. Transfus Med: 2002; 12 3 193 198 (Pubitemid 34685874)
28. Warkentin TE, Linkins LA. Immunoassays are not created equal. J Thromb Haemost: 2009; 7 8 1256 1259
29. Schneiter S, Colucci G, Sulzer I, Barizzi G, Lämmle B, Alberio L. Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA. J Thromb Haemost: 2009; 7 10 1649 1655
30. Warkentin TE, Sheppard JI, Raschke R, Greinacher A. Performance characteristics of a rapid assay for anti-PF4/heparin antibodies: the particle immunofiltration assay. J Thromb Haemost: 2007; 5 11 2308 2310 (Pubitemid 47617888)
31. Warkentin TE, Sheppard JI, Moore JC, Kelton JG. The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost: 2010; 8 1 216 218
32. Newman PM, Swanson RL, Chong BH. Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid. Thromb Haemost: 1998; 80 2 292 297 (Pubitemid 28393626)
33. Bakchoul T, Giptner A, Bein G, Santoso S, Sachs UJ. Performance characteristics of two commercially available IgG-specific immunoassays in the assessment of heparin-induced thrombocytopenia (HIT). Thromb Res: 2011; 127 4 345 348
34. Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Eur J Haematol: 2006; 76 5 420 426
35. Greinacher A. Too many hits in HIT? Am J Hematol: 2007; 82 12 1035 1036
36. Martin-Toutain I, Piette JC, Diemert MC, Faucher C, Jobic L, Ankri A. High prevalence of antibodies to platelet factor 4 heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopenia. Lupus: 2007; 16 2 79 83 (Pubitemid 46347928)
37. Pauzner R, Greinacher A, Selleng K, Althaus K, Shenkman B, Seligsohn U. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost: 2009; 7 7 1070 1074
38. Whitlatch NL, Perry SL, Ortel TL. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost: 2008; 100 4 678 684
39. Selleng S, Malowsky B, Itterman T., et al. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery. Am Heart J: 2010; 160 2 362 369
40. Smythe MA, Warkentin TE, Woodhouse AL, Zakalik D. Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT "overdiagnosiso" in a patient with antiphospholipid syndrome. Am J Hematol: 2011; 86 2 188 191
41. Pouplard C, Leroux D, Regina S, Rollin J, Gruel Y. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies. Thromb Haemost: 2010; 103 1 145 150
42. Morel-Kopp MC, Aboud M, Tan CW, Kulathilake C, Ward C. Heparin-induced thrombocytopenia: evaluation of IgG and IgGAM ELISA assays. Int J Lab Hematol: 2011; 33 3 245 250
43. Greinacher A, Ittermann T, Bagemühl J., et al. Heparin-induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests. J Thromb Haemost: 2010; 8 9 2025 2031
44. Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost: 2004; 2 12 2133 2137 (Pubitemid 40185772)
45. Whitlatch NL, Kong DF, Metjian AD, Arepally GM, Ortel TL. Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia. Blood: 2010; 116 10 1761 1766
46. Warkentin TE, Sheppard JI. No significant improvement in diagnostic specificity of an anti-PF4/polyanion immunoassay with use of high heparin confirmatory procedure. J Thromb Haemost: 2006; 4 1 281 282
47. Selleng S, Schreier N, Wollert HG, Greinacher A. The diagnostic value of the anti-PF4/heparin immunoassay high-dose heparin confirmatory test in cardiac surgery patients. Anesth Analg: 2011; 112 4 774 776
48. Althaus K, Strobel U, Warkentin TE, Greinacher A. Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay. Thromb Res: 2011; 128 3 256 260
49. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood: 1986; 67 1 27 30 (Pubitemid 16167006)
50. Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost: 1991; 66 6 734 736
51. Morel MC, Lecompte T, Champeix P., et al. PL2-49, a monoclonal antibody against glycoprotein IIb which is a platelet activator. Br J Haematol: 1989; 71 1 57 63 (Pubitemid 19047698)
52. Ockenhouse CF, Magowan C, Chulay JD. Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro. J Clin Invest: 1989; 84 2 468 475 (Pubitemid 19196977)
53. Worthington RE, Carroll RC, Boucheix C. Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor. Br J Haematol: 1990; 74 2 216 222 (Pubitemid 20041098)
54. Warmerdam PA, van de Winkel JG, Gosselin EJ, Capel PJ. Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). J Exp Med: 1990; 172 1 19 25 (Pubitemid 20217241)
55. Clark MR, Stuart SG, Kimberly RP, Ory PA, Goldstein IM. A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor II on human monocytes. Eur J Immunol: 1991; 21 8 1911 1916
56. Tomiyama Y, Kunicki TJ, Zipf TF, Ford SB, Aster RH. Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression. Blood: 1992; 80 9 2261 2268
57. Norris CF, Pricop L, Millard SS., et al. A naturally occurring mutation in Fc gamma RIIA: a Q to K127 change confers unique IgG binding properties to the R131 allelic form of the receptor. Blood: 1998; 91 2 656 662 (Pubitemid 28053391)
58. Bachelot-Loza C, Saffroy R, Lasne D, Chatellier G, Aiach M, Rendu F. Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis. Thromb Haemost: 1998; 79 3 523 528 (Pubitemid 28120784)
59. Morel-Kopp MC, Aboud M, Tan CW, Kulathilake C, Ward C. Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies. Thromb Res: 2010; 125 5 e234 e239
60. Price EA, Hayward CP, Moffat KA, Moore JC, Warkentin TE, Zehnder JL. Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: a survey of North American specialized coagulation laboratories. Thromb Haemost: 2007; 98 6 1357 1361 (Pubitemid 350239110)
61. Tardy-Poncet B, Piot M, Chapelle C., et al. Thrombin generation and heparin-induced thrombocytopenia. J Thromb Haemost: 2009; 7 9 1474 1481
62. Nowak G. Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease. Thromb Haemost: 2009; 102 5 887 891
63. Fratantoni JC, Pollet R, Gralnick HR. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. Blood: 1975; 45 3 395 401
64. Chong BH, Pitney WR, Castaldi PA. Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation. Lancet: 1982; 2 8310 1246 1249
65. Berkowitz SD, Frelinger AL III, Hillman RS. Progress in point-of-care laboratory testing for assessing platelet function. Am Heart J: 1998; 136 4 Pt 2 Su S51 S65 (Pubitemid 28487159)
66. Harrison P. Platelet function analysis. Blood Rev: 2005; 19 2 111 123 (Pubitemid 39643116)
67. Favaloro EJ, Lippi G, Franchini M. Contemporary platelet function testing. Clin Chem Lab Med: 2010; 48 5 579 598
68. Greinacher A, Kohlmann T, Strobel U, Sheppard JA, Warkentin TE. The temporal profile of the anti-PF4/heparin immune response. Blood: 2009; 113 20 4970 4976
69. Eichler P, Budde U, Haas S., et al. First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA. Thromb Haemost: 1999; 81 4 625 629 (Pubitemid 29178953)
70. Elalamy I, Galea V, Hatmi M, Gerotziafas GT. Heparin-induced multiple electrode aggregometry: a potential tool for improvement of heparin-induced thrombocytopenia diagnosis. J Thromb Haemost: 2009; 7 11 1932 1934
71. Khairy M, Lasne D, Brohard-Bohn B, Aiach M, Rendu F, Bachelot-Loza C. A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia. Formation of leukocyte-platelet aggregates. Thromb Haemost: 2001; 85 6 1090 1096 (Pubitemid 32573765)
72. Warkentin TE, Sheppard JI. Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG/serum and other IgG platelet agonists: a comparison with standard platelet agonists. Platelets: 1999; 10 5 319 326 (Pubitemid 29490859)
73. Mullier F, Bailly N, Cornet Y., et al. Contribution of platelet microparticles generation assay to the diagnosis of type II heparin-induced thrombocytopenia. Thromb Haemost: 2010; 103 6 1277 1281
74. Jy W, Mao WW, Horstman LL, Valant PA, Ahn YS. A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT). Thromb Haemost: 1999; 82 4 1255 1259 (Pubitemid 29473788)
75. Tomer A. A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia. Br J Haematol: 1997; 98 3 648 656 (Pubitemid 27386546)
76. Gobbi G, Mirandola P, Tazzari PL., et al. New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia. Cytometry B Clin Cytom: 2004; 58 1 32 38 (Pubitemid 38332718)
77. Prechel MM, McDonald MK, Jeske WP, Messmore HL, Walenga JM. Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin. J Thromb Haemost: 2005; 3 10 2168 2175 (Pubitemid 41727193)
78. Socher I, Kroll H, Jorks S, Santoso S, Sachs UJ. Heparin-independent activation of platelets by heparin-induced thrombocytopenia antibodies: a common occurrence. J Thromb Haemost: 2008; 6 1 197 200
79. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood: 2005; 106 8 2710 2715 (Pubitemid 41510744)
80. Toulon P, Costa JM, Amiral J. An enzyme-linked immunosorbent assay for heparin cofactor II (HCII). Application to the measurement of HCII in clinical materials. Clin Chim Acta: 1992; 205 1-2 65 73
81. Risch L, Bertschmann W, Heijnen IA, Huber AR. A differentiated approach to assess the diagnostic usefulness of a rapid particle gel immunoassay for the detection of antibodies against heparin-platelet factor 4 in cardiac surgery patients. Blood Coagul Fibrinolysis: 2003; 14 1 99 106 (Pubitemid 36206731)
82. Morel-Kopp MC, Tan CW, Brighton TA., et al. Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT. Results of a large Australian Study. Thromb Haemost: 2012; 107 3 [Epub ahead of print]